Research Groups

Section of Molecular Pathology

Recent Publications - 12 most recent publications

1. Anantharaman D., Abedi-Ardekani B., Beachler D. C., Gheit T., Olshan A. F., Wisniewski K., Wunsch-Filho V., Toporcov T. N., Tajara E. H., Levi J. E., Moyses R. A., Boccia S., Cadoni G., Rindi G., Ahrens W., Merletti F., Conway D. I., Wright S., Carreira C., Renard H., Chopard P., McKay-Chopin S., Scelo G., Tommasino M., Brennan P., D'Souza G. (2017) Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer Int J Cancer; 140(9):1968-1975. PMID: 28108990

2. Wang Q., Satomi K., Oh J. E., Hutter B., Brors B., Diessl N., Liu H. K., Wolf S., Wiestler O., Kleihues P., Koelsch B., Kindler-Rohrborn A., Ohgaki H. (2016) Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea Am J Pathol; 186(10):2569-76. PMID: 27658714

3. Oh J. E., Ohta T., Nonoguchi N., Satomi K., Capper D., Pierscianek D., Sure U., Vital A., Paulus W., Mittelbronn M., Antonelli M., Kleihues P., Giangaspero F., Ohgaki H. (2016) Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma Brain Pathol; 26(4):517-22. PMID: 26443480

4. Gramatzki D., Dehler S., Rushing E. J., Zaugg K., Hofer S., Yonekawa Y., Bertalanffy H., Valavanis A., Korol D., Rohrmann S., Pless M., Oberle J., Roth P., Ohgaki H., Weller M. (2016) Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009 Cancer; 122(14):2206-15. PMID: 27088883

5. Zhao F., Ohgaki H., Xu L., Giangaspero F., Li C., Li P., Yang Z., Wang B., Wang X., Wang Z., Ai L., Zhang J., Luo L., Liu P. (2016) Molecular subgroups of adult medulloblastoma: a long-term single-institution study Neuro Oncol; 18(7):982-90. PMID: 27106407

6. Louis D. N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W. K., Ohgaki H., Wiestler O. D., Kleihues P., Ellison D. W. (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary Acta Neuropathol; 131(6):803-20. PMID: 27157931

7. Stewart B. W., Bray F., Forman D., Ohgaki H., Straif K., Ullrich A., Wild C. P. (2016) Cancer prevention as part of precision medicine: 'plenty to be done' Carcinogenesis; 37(1):2-9. PMID: 26590901

8. Walsh K. M., Ohgaki H., Wrensch M. R. (2016) Epidemiology Handb Clin Neurol; 3-18. PMID: 26948345

9. Parroche P., Roblot G., Le Calvez-Kelm F., Tout I., Marotel M., Malfroy M., Durand G., McKay J., Ainouze M., Carreira C., Allatif O., Traverse-Glehen A., Mendiola M., Pozo-Kreilinger J. J., Caux C., Tommasino M., Goutagny N., Hasan U. A. (2016) TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression Oncogenesis; 5(7):e244. PMID: 27454079

10. Oh J.E., Ohta T., Satomi K., Foll M., Durand G., McKay J., Le Calvez-Kelm F., Mittelbronn M., Brokinkel B., Paulus W., Ohgaki H. (2015) Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas J Neuropathol. Exp. Neurol; 74(10):952-959. PMID: 26360373

11. Kim Y.H., Ohta T., Oh J.E., Le Calvez-Kelm F., McKay J., Voegele C., Durand G., Mittelbronn M., Kleihues P., Paulus W., Ohgaki H. (2014) TP53, MSH4, and LATS1 Germline Mutations in a Family with Clustering of Nervous System Tumors Am J Pathol; 184(9):2374-2381.

12. Fiaschetti G., Abela L., Nonoguchi N., Dubuc A.M., Remke M., Boro A., Grunder E., Siler U., Ohgaki H., Taylor M.D., Baumgartner M., Shalaby T., Grotzer M.A. (2014) Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma Br J Cancer; 110(3):636-647.